Partnering Opportunities

A central element of our corporate strategy is to leverage the product development engine the company has created with its partners to advance CNS products into and through clinical development. Embera strives to develop productive partnerships and collaborations in order to optimize late-preclinical to late-clinical stage development and maximize the worldwide commercial potential of the range of indications in development. In addition, the Company seeks to identify promising CNS compounds that address significant unmet medical needs that can expand Embera’s product pipeline and leverage the expertise of the Embera team and our development partners to advance products into and through clinical development.

Please contact us if you would like to learn more about Embera’s partnering initiatives.